Publications by authors named "N V Baryshnikova"

Despite great advances in the treatment of oncological diseases, the development of medical technologies to prevent or reduce complications of therapy, in particular, those associated with surgery and the introduction of antibiotics, remains relevant. The aim of this study is to evaluate the effectiveness of the use of autoprobiotics based on indigenous non-pathogenic strains of and as a personalized functional food product (PFFP) in the complex therapy of colorectal cancer (CRC) in the early postoperative period. A total of 36 patients diagnosed with CRC were enrolled in the study.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to evaluate how effective Regasthym Gastro (alpha-glutamyl-tryptophan) is in reducing inflammation in patients suffering from chronic atrophic gastritis, using both endoscopic and morphometric methods.
  • - Conducted as a double-blind placebo-controlled trial, the research involved analyzing the results from 80 patients, with 43 receiving Regasthym and 37 receiving a placebo, focusing on various gastric mucosa conditions and histological assessments.
  • - Results indicated significant improvements in the severity of gastric mucosa inflammation after treatment with Regasthym, including reductions in edema and overall inflammatory signs, correlating well with various immune cell metrics.
View Article and Find Full Text PDF

Joubert syndrome (JS) is a recessive disorder that is characterized by midbrain-hindbrain malformation and shows the "molar tooth sign" on magnetic resonance imaging. Mutations in 40 genes, including Abelson helper integration site 1 (), inositol polyphosphate-5-phosphatase (), coiled-coil and c2 domain-containing protein 2A (), and ARL2-like protein 1 (), can cause JS. Classic JS is a part of a group of diseases associated with JS, and its manifestations include various neurological signs such as skeletal abnormalities, ocular coloboma, renal disease, and hepatic fibrosis.

View Article and Find Full Text PDF

Road traffic accidents are a pervasive feature of everyday life, killing 36,500 people, injuring 4.5 million and, overall, generating costs to the American society of $340 billion in 2019. Understanding the underlying factors can improve the design of prevention strategies.

View Article and Find Full Text PDF

The article discusses various approaches for probiotic treatment of () infection: Probiotics as an adjuvant treatment in the standard eradication therapy; probiotic strains as a monotherapy; and autoprobiotics as a monotherapy. Autoprobiotics refer to indigenous bifidobacteria, lactobacilli, or enterococci isolated from a specific individual, intended to restore his/her microbiota and improve his/her health. The potential mechanisms of probiotic action against include correction of the gut microbiota, immunological effects (enhancement of humoral and cellular immunity, and reduction of oxidative stress), direct antagonistic effects against (such as colonization resistance and bacteriocin synthesis), and stimulation of local immunological protection (strengthening of the mucous protective barrier and reduction of gastric mucosa inflammation).

View Article and Find Full Text PDF